JP2022507373A5 - - Google Patents
Info
- Publication number
- JP2022507373A5 JP2022507373A5 JP2021526247A JP2021526247A JP2022507373A5 JP 2022507373 A5 JP2022507373 A5 JP 2022507373A5 JP 2021526247 A JP2021526247 A JP 2021526247A JP 2021526247 A JP2021526247 A JP 2021526247A JP 2022507373 A5 JP2022507373 A5 JP 2022507373A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- polypeptide
- composition according
- seq
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1818576.9 | 2018-11-14 | ||
| GBGB1818576.9A GB201818576D0 (en) | 2018-11-14 | 2018-11-14 | Arginase 2 polypeptides |
| PCT/EP2019/081369 WO2020099582A1 (en) | 2018-11-14 | 2019-11-14 | Immunogenic arginase 2 polypeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022507373A JP2022507373A (ja) | 2022-01-18 |
| JP2022507373A5 true JP2022507373A5 (https=) | 2022-08-30 |
| JP7611137B2 JP7611137B2 (ja) | 2025-01-09 |
Family
ID=64739444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021526247A Active JP7611137B2 (ja) | 2018-11-14 | 2019-11-14 | 免疫原性アルギナーゼ２ポリペプチド |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12234288B2 (https=) |
| EP (1) | EP3880225A1 (https=) |
| JP (1) | JP7611137B2 (https=) |
| KR (1) | KR20210093287A (https=) |
| CN (1) | CN113164545B (https=) |
| AU (1) | AU2019378076B2 (https=) |
| CA (1) | CA3118794A1 (https=) |
| GB (1) | GB201818576D0 (https=) |
| IL (1) | IL283133B1 (https=) |
| SG (1) | SG11202104881VA (https=) |
| WO (1) | WO2020099582A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201818576D0 (en) * | 2018-11-14 | 2018-12-26 | Io Biotech Aps | Arginase 2 polypeptides |
| GB201912030D0 (en) * | 2019-08-21 | 2019-10-02 | Cancer Research Tech Ltd | Binding molecules |
| US20250327041A1 (en) | 2022-02-24 | 2025-10-23 | Io Biotech Aps | Nucleotide delivery of cancer therapy |
| KR20240159833A (ko) | 2022-02-24 | 2024-11-06 | 아이오 바이오테크 에이피에스 | 아르기나아제 2 백신 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US58767A (en) | 1866-10-16 | John brougjbton | ||
| US5554372A (en) | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
| US5780286A (en) * | 1996-03-14 | 1998-07-14 | Smithkline Beecham Corporation | Arginase II |
| CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| EP1474528A4 (en) * | 2000-10-13 | 2006-06-14 | Protein Design Labs Inc | METHODS OF DIAGNOSIS OF PROSTATE CANCER, COMPOSITIONS AND METHODS OF EXAMINING PROSTATE CANCER MODULATORS |
| US20070014801A1 (en) * | 2001-01-24 | 2007-01-18 | Gish Kurt C | Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| CA2742497C (en) | 2008-10-31 | 2024-01-23 | George Georgiou | Compositions of engineered human arginases and methods for treating cancer |
| BR112017022845A2 (pt) * | 2015-04-23 | 2018-07-17 | Nantomics, Llc | neoepítopos de câncer |
| HRP20240052T1 (hr) | 2016-03-04 | 2024-03-29 | Io Biotech Aps | Kombinirana terapija protiv raka |
| GB2568000A (en) | 2016-08-08 | 2019-05-01 | Aerase Inc | Compositions and methods for treating cancer with arginine depletion and immuno oncology agents |
| AU2017341112B2 (en) * | 2016-10-07 | 2024-06-27 | Io Biotech Aps | Immunogenic arginase peptides |
| GB201815549D0 (en) | 2018-09-24 | 2018-11-07 | Io Biotech Aps | Arginase1 polypeptides |
| GB201818576D0 (en) * | 2018-11-14 | 2018-12-26 | Io Biotech Aps | Arginase 2 polypeptides |
-
2018
- 2018-11-14 GB GBGB1818576.9A patent/GB201818576D0/en not_active Ceased
-
2019
- 2019-11-14 US US17/293,325 patent/US12234288B2/en active Active
- 2019-11-14 CA CA3118794A patent/CA3118794A1/en active Pending
- 2019-11-14 SG SG11202104881VA patent/SG11202104881VA/en unknown
- 2019-11-14 AU AU2019378076A patent/AU2019378076B2/en active Active
- 2019-11-14 KR KR1020217017730A patent/KR20210093287A/ko active Pending
- 2019-11-14 CN CN201980075475.8A patent/CN113164545B/zh active Active
- 2019-11-14 WO PCT/EP2019/081369 patent/WO2020099582A1/en not_active Ceased
- 2019-11-14 EP EP19805931.3A patent/EP3880225A1/en active Pending
- 2019-11-14 JP JP2021526247A patent/JP7611137B2/ja active Active
-
2021
- 2021-05-12 IL IL283133A patent/IL283133B1/en unknown
-
2025
- 2025-01-17 US US19/028,166 patent/US20250388674A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022507373A5 (https=) | ||
| KR100767554B1 (ko) | 암 억제 유전자 더블유티1의 생산물에 기초한 암항원 | |
| JP2022095926A (ja) | 乳癌再発の予防のためのワクチン | |
| RU2011108315A (ru) | Индуцирующий иммунитет агент | |
| JP2018526428A5 (https=) | ||
| JP2022535102A5 (https=) | ||
| JP7099956B2 (ja) | がんの治療のためのｍｉｃａ／ｂアルファ３ドメインによるワクチン接種 | |
| JP2024513559A5 (https=) | ||
| JP2022130623A5 (https=) | ||
| RU2017128465A (ru) | Неприродные семафорины класса 3 и их медицинское применение | |
| JP2008530975A5 (https=) | ||
| RU2011110376A (ru) | Эпитопные пептиды hig2 и urlc10 и содержание их вакцины | |
| EP1469869B1 (en) | Peptide useful in immunomodulation | |
| AU2013249522A1 (en) | Multivalent breast cancer vaccine | |
| CN112203663A (zh) | Cpg两亲分子及其用途 | |
| CN101754768A (zh) | 用作癌症疫苗的存活蛋白肽 | |
| EP2766384B1 (en) | Toll-like receptor 4 (tlr-4) agonist peptides for modulating tlr-4 mediated immune response | |
| CN106456728A (zh) | 恢复对抗癌症的nkg2d通路功能的疫苗组合物和方法 | |
| CA2432971A1 (en) | Polypeptides | |
| WO2017177910A1 (zh) | 增强抗肿瘤免疫反应的新型免疫策略和免疫组合物 | |
| ES2390967T3 (es) | Epítopo/péptido reconocido por LTC específico para Ep-CAM con restricción por ALH-A2402 y su utilización | |
| CN111118063B (zh) | 以FAPα和survivin为基础的DNA及其在制备肿瘤疫苗中的应用 | |
| US8207141B2 (en) | Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof | |
| JP2007511534A5 (https=) | ||
| CN101648011A (zh) | 一种肿瘤靶向重组dna疫苗及其制备与应用 |